Cellect biotechnology ltd. (APOP)
Balance Sheet / Quarterly
Jun'18Dec'17
Assets [abstract]
CURRENT ASSETS:
Cash and cash equivalents

5,706

3,961

Short-term deposits

1,000

0

Marketable securities

1,507

4,038

Other receivables

254

236

CURRENT ASSETS

8,467

8,235

LONG-TERM ASSETS:
Restricted cash

91

88

Other long term assets

42

50

Property, plant and equipment, net

376

388

Non-current assets

509

526

Assets

8,976

8,761

Liabilities [abstract]
CURRENT LIABILITIES:
Trade payables

308

491

Other payables

513

691

Current liabilities

821

1,182

NON CURRENT LIABILITIES:
Warrants to ADS

2,095

-

Warrants to ADS

-

2,141

CONTINGENT LIABILITIES AND COMMITMENTS

-

0

SHAREHOLDERS' EQUITY :
Ordinary shares of no par value: Authorized: 500,000,000 shares at December 31, 2017 and June 30, 2018 (unaudited); Issued and outstanding: 120,185,659*) at December 31, 2017; and 130,192,799*) at June 30, 2018 (unaudited).

0

0

Additional paid-in capital

25,931

23,894

Share-based payments and proceeds from conversion option

2,850

2,706

Treasury shares

2,582

2,718

Accumulated deficit

-20,139

-18,444

Equity

6,060

5,438

Equity and liabilities

8,976

8,761